Markets:

Overview

News

Currencies

International

Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

9.820 +0.230 (+2.40%)

Streaming Delayed Price Updated: 10:18 AM EDT, Jun 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Personalis to Announce Second Quarter 2025 Financial Results

July 22, 2025

From Personalis, Inc.

Via Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025

From Personalis, Inc.

Via Business Wire

Cramer Says Tesla Dominates While Ouster Is 'Too Speculative' ↗

July 10, 2025

Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan American as a profitable alternative. Insmed is also considered speculative while the only viable option for...

Via Benzinga

Topics Artificial Intelligence

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) ↗

January 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 09, 2025

Via Benzinga

What's going on in today's after hours session ↗

July 09, 2025

Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

July 09, 2025

From Personalis, Inc.

Via Business Wire

Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO

June 03, 2025

From Personalis, Inc.

Via Business Wire

New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse

June 02, 2025

From Personalis, Inc.

Via Business Wire

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection

May 22, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference

May 14, 2025

From Personalis, Inc.

Via Business Wire

Analyst Expectations For Personalis's Future ↗

May 07, 2025

Via Benzinga

Personalis Reports First Quarter 2025 Financial Results

May 06, 2025

From Personalis, Inc.

Via Business Wire

Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study

April 28, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Announce First Quarter 2025 Financial Results

April 22, 2025

From Personalis, Inc.

Via Business Wire

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection

April 22, 2025

From Personalis, Inc.

Via Business Wire

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. ↗

April 17, 2025

A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

Via Investor's Business Daily

What 5 Analyst Ratings Have To Say About Personalis ↗

April 10, 2025

Via Benzinga

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference

March 26, 2025

From Personalis, Inc.

Via Business Wire

This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

March 17, 2025

Via Benzinga

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip ↗

March 08, 2025

Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.

Via Benzinga

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

March 03, 2025

From Personalis, Inc.

Via Business Wire

Personalis Reports Fourth Quarter and Full Year 2024 Financial Results

February 27, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

February 18, 2025

From Personalis, Inc.

Via Business Wire

Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday ↗

February 14, 2025

Via Benzinga

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

February 13, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 28, 2025

From Personalis, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.